184 related articles for article (PubMed ID: 24801127)
1. Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease.
Ataga KI; Hinderliter A; Brittain JE; Jones S; Xu H; Cai J; Kim S; Pritchard KA; Hillery CA
Hematology; 2015 Jun; 20(5):289-96. PubMed ID: 24801127
[TBL] [Abstract][Full Text] [Related]
2. Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease.
Seixas MO; Rocha LC; Carvalho MB; Menezes JF; Lyra IM; Nascimento VM; Couto RD; Atta ÁM; Reis MG; Goncalves MS
Lipids Health Dis; 2010 Aug; 9():91. PubMed ID: 20799970
[TBL] [Abstract][Full Text] [Related]
3. Monocytosis is associated with hemolysis in sickle cell disease.
Wongtong N; Jones S; Deng Y; Cai J; Ataga KI
Hematology; 2015 Dec; 20(10):593-7. PubMed ID: 25875078
[TBL] [Abstract][Full Text] [Related]
4. Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension.
Zorca S; Freeman L; Hildesheim M; Allen D; Remaley AT; Taylor JG; Kato GJ
Br J Haematol; 2010 May; 149(3):436-45. PubMed ID: 20230401
[TBL] [Abstract][Full Text] [Related]
5. Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation.
Yalcinkaya A; Unal S; Oztas Y
Lipids Health Dis; 2019 Dec; 18(1):225. PubMed ID: 31861992
[TBL] [Abstract][Full Text] [Related]
6. Association of coagulation activation with clinical complications in sickle cell disease.
Ataga KI; Brittain JE; Desai P; May R; Jones S; Delaney J; Strayhorn D; Hinderliter A; Key NS
PLoS One; 2012; 7(1):e29786. PubMed ID: 22253781
[TBL] [Abstract][Full Text] [Related]
7. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
[TBL] [Abstract][Full Text] [Related]
8. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
[TBL] [Abstract][Full Text] [Related]
9. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
10. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.
El-Shanshory M; Badraia I; Donia A; Abd El-Hameed F; Mabrouk M
Eur J Haematol; 2013 Jul; 91(1):55-61. PubMed ID: 23551575
[TBL] [Abstract][Full Text] [Related]
12. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.
Aleluia MM; da Guarda CC; Santiago RP; Fonseca TC; Neves FI; de Souza RQ; Farias LA; Pimenta FA; Fiuza LM; Pitanga TN; Ferreira JR; Adorno EV; Cerqueira BA; Gonçalves MS
Lipids Health Dis; 2017 Apr; 16(1):74. PubMed ID: 28399852
[TBL] [Abstract][Full Text] [Related]
13. Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine.
Samarah F; Srour MA; Dumaidi K
Biomed Res Int; 2021; 2021():6640956. PubMed ID: 34395622
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
15. Lipid profiles in French West Indies sickle cell disease cohorts, and their general population.
Lalanne-Mistrih ML; Connes P; Lamarre Y; Lemonne N; Hardy-Dessources MD; Tarer V; Etienne-Julan M; Mougenel D; Tressières B; Romana M
Lipids Health Dis; 2018 Mar; 17(1):38. PubMed ID: 29506549
[TBL] [Abstract][Full Text] [Related]
16. On artherogenic index of plasma in sickle cell anaemia patients.
Akinbami AA; Uche EI; Suleiman AM; Ogbenna AA; Olowoselu FO; Augustine B; Badiru MA; Bamiro RA; Kamson OR
Pan Afr Med J; 2019; 32():141. PubMed ID: 31308859
[TBL] [Abstract][Full Text] [Related]
17. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.
Liem RI; Young LT; Thompson AA
Haematologica; 2007 Nov; 92(11):1549-52. PubMed ID: 18024403
[TBL] [Abstract][Full Text] [Related]
18. Hypocholesterolemia in Nigerian children with sickle cell disease.
VanderJagt DJ; Shores J; Okorodudu A; Okolo SN; Glew RH
J Trop Pediatr; 2002 Jun; 48(3):156-61. PubMed ID: 12164599
[TBL] [Abstract][Full Text] [Related]
19. Lipid and hemolysis parameters predicting acute chest syndrome in adulthood with sickle cell disease.
Feugray G; Grall M; Dumesnil C; Brunel V; Benhamou Y; Quillard Muraine M; Billoir P
Lipids Health Dis; 2024 May; 23(1):140. PubMed ID: 38755670
[TBL] [Abstract][Full Text] [Related]
20. Featured Article: Depletion of HDL
Soupene E; Larkin SK; Kuypers FA
Exp Biol Med (Maywood); 2017 Jun; 242(12):1244-1253. PubMed ID: 28436274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
